Innovation and demand keep the IOL market in sharp focus through 2032, DelveInsight predicts.
According to a recent report by DelveInsight Business Research (Gurugram, India), the global intraocular lens (IOL) market is projected to expand at a steady compound annual growth rate (CAGR) of 6.12% through 2032. This growth is primarily fueled by the rising prevalence of cataracts, presbyopia and astigmatism—conditions that continue to drive demand for corrective eye surgery worldwide.
Momentum is further boosted by greater access to eye care, particularly in emerging economies where awareness campaigns and stronger medical infrastructure are enabling earlier diagnosis and treatment. As a result, more patients are seeking advanced surgical solutions that deliver sharper vision and enhanced quality of life.
With expanding product pipelines and increasing regulatory approvals, the IOL market is projected to reach $7.41 billion by 2032, solidifying its position as a key growth area within ophthalmology.
Innovation driving market momentum
A key driver in the IOL sector is the ongoing evolution of lens materials and designs. Today’s modern lenses—multifocal, toric and extended depth of focus (EDOF) IOLs—are raising patient satisfaction by providing clearer vision across varying focal lengths.
In recent years, manufacturers have invested heavily in developing personalized IOL solutions tailored to specific patient needs. In October 2024, for example, Bausch + Lomb (Laval, Canada) received U.S. Food and Drug Administration (FDA) approval for the enVista Envy full-range-of-vision IOL, a product designed to deliver comprehensive visual clarity.
Similarly, the Apthera IOL achieved FDA approval as the first small-aperture IOL approved for implantation alongside a monofocal or toric lens—a breakthrough signaling a new era in customized cataract care.
READ MORE: https://cakemagazine.org/essilorluxottica-to-acquire-optegra/
Regional insights
According to DelveInsight, North America currently leads the global IOL market, supported by advanced healthcare infrastructure, a high concentration of specialized eye centers and strong demand for cutting-edge surgical options.
DelveInsight reports on the future of myopia treatment devices, including innovations, challenges and future trends.
The region also benefits from the ongoing innovations of major ophthalmic players such as Johnson & Johnson Vision (California, USA), Alcon (Geneva, Switzerland) and ZEISS (Oberkochen, Germany), which continue to introduce state-of-the-art devices that meet the evolving needs of both surgeons and patients.
READ MORE: https://cakemagazine.org/ascrs-artificial-intelligence-tools-in-ophthalmology/
A clear future for vision care
As the world’s population continues to grow and age, demand for premium intraocular lenses—especially those correcting multiple visual impairments—will only intensify. The convergence of advanced materials, precise surgical techniques and digital innovations points toward a future where restoring clear vision is not merely possible, but fully personalized.
Editor’s Note: This content is intended exclusively for healthcare professionals. It is not intended for the general public. Products or therapies discussed may not be registered or approved in all jurisdictions, including Singapore.